Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Inha mouse shows promise as a model for male reproductive development

March 7, 2013

DRI unveils BioHub project for treatment of type 1 diabetes

March 7, 2013

Eli Lilly patents novel GPR40 agonists for diabetes

March 7, 2013

FDA committee votes on approval of low-dose mesylate salt of paroxetine

March 6, 2013

Dicer1 gene linked to sperm maturation

March 6, 2013

Rbm5 proves essential for the progression of spermatogenesis

March 6, 2013

FDA advisory committee votes against approval of Depomed's Sefelsa

March 6, 2013

EMA grants orphan drug status to Prothena's candidate for amyloid light-chain amyloidosis

March 5, 2013

Promethera Biosciences opens French site in phase I/II HepaStem trial

March 5, 2013

Novo Nordisk launches new long-acting insulin Tresiba in Denmark

March 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...